Pacific Shuanglin Bio-pharmacy Co., LTD (SHE:000403)
22.56
+0.43 (1.94%)
Jun 3, 2025, 2:45 PM CST
SHE:000403 Revenue
Pacific Shuanglin Bio-pharmacy Co., LTD had revenue of 374.65M CNY in the quarter ending March 31, 2025, a decrease of -14.00%. This brings the company's revenue in the last twelve months to 2.59B, up 3.60% year-over-year. In the year 2024, Pacific Shuanglin Bio-pharmacy Co., LTD had annual revenue of 2.65B with 14.00% growth.
Revenue (ttm)
2.59B
Revenue Growth
+3.60%
P/S Ratio
6.36
Revenue / Employee
984.32K
Employees
2,635
Market Cap
16.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.65B | 325.96M | 14.00% |
Dec 31, 2023 | 2.33B | -76.47M | -3.18% |
Jan 1, 2023 | 2.41B | 433.45M | 21.98% |
Jan 1, 2022 | 1.97B | 921.80M | 87.80% |
Jan 1, 2021 | 1.05B | 134.28M | 14.67% |
Jan 1, 2020 | Pro | Pro | Pro |
Jan 1, 2019 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Aier Eye Hospital Group | 21.81B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |